Homocysteine level in obese people with corona virus patients in Iraq

Ahmed Ridha Abduljawad; Muntadher Mohammad Ali; Huda Falah Judi

doi:10.53730/ijhs.v6nS9.13530

Authors

Ahmed Ridha Abduljawad Department of Chemistry, College of Science, University of Kufa, Iraq
Muntadher Mohammad Ali
muntadhar.aljalal@uokufa.edu.iq
Department of Chemistry, College of Science, University of Kufa, Iraq Huda
Huda Falah Judi Department of Chemistry, College of Science, University of Kufa, Iraq

Keywords:

COVID-19, SARS-CoV-2, thyroid hormone, TSH, vitamin C

Abstract

Background: Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, it has affected >200 countries, areas, or territories in 6 continents. At present, whether COVID-19 has an effect on thyroid function is unclear. The aim of this study was to evaluate thyroid function in iraqi patients with COVID-19. Methods: Clinical features, laboratory results, and real time PCR were reviewed for 60 patients with laboratory-confirmed COVID-19 without a history of thyroid disease. They were admitted to the Al-Sadr Teaching Hospital; Iraq between September and December 2021. Healthy participants who underwent routine physical checkups and non-COVID-19 patients the study as the control group. Homocysteine and IL6 levels were determine and compared between the obese COVID-19 and control groups. Results: Homocysteine higher than the normal range of the patients with COVID-19 Compared to the control group. The levels of TSH and serum triiodothyronine (T3) of the patients with COVID-19 were significantly lower than those of the healthy control group. The lower the TSH and T3 levels were, with statistical significance (p <0.001). The degree of the decreases in TSH and T3 levels was positively correlated with the severity of the disease.

Downloads

Download data is not yet available.

References

Azkur, Ahmet Kursat, Mübeccel Akdis, Dilek Azkur, Milena Sokolowska, Willem van de Veen, Marie Charlotte Brüggen, Liam O’Mahony, Yadong Gao, Kari Nadeau, and Cezmi A. Akdis. 2020. “Immune Response to SARS-CoV-2 and Mechanisms of Immunopathological Changes in COVID-19.” Allergy: European Journal of Allergy and Clinical Immunology. Blackwell Publishing Ltd. https://doi.org/10.1111/all.14364.

Carpenè, Giovanni, Davide Negrini, Brandon M. Henry, Martina Montagnana, and Giuseppe Lippi. 2022. “Homocysteine in Coronavirus Disease (COVID-19): A Systematic Literature Review.” Diagnosis 0 (0). https://doi.org/10.1515/dx-2022-0042.

Chrysant, Steven G., and George S. Chrysant. 2018. “The Current Status of Homocysteine as a Risk Factor for Cardiovascular Disease: A Mini Review.” Expert Review of Cardiovascular Therapy. Taylor and Francis Ltd. https://doi.org/10.1080/14779072.2018.1497974.

Hou, Huimin, and Huiying Zhao. 2021. “Epigenetic Factors in Atherosclerosis: DNA Methylation, Folic Acid Metabolism, and Intestinal Microbiota.” Clinica Chimica Acta. Elsevier B.V. https://doi.org/10.1016/j.cca.2020.11.013.

Huang, Chaolin, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, et al. 2020. “Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China.” The Lancet 395 (10223): 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.

Koklesova, Lenka, Alena Mazurakova, Marek Samec, Kamil Biringer, Samson Mathews Samuel, Dietrich Büsselberg, Peter Kubatka, and Olga Golubnitschaja. 2021. “Homocysteine Metabolism as the Target for Predictive Medical Approach, Disease Prevention, Prognosis, and Treatments Tailored to the Person.” EPMA Journal. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s13167-021-00263-0.

Kwok, See, Safwaan Adam, Jan Hoong Ho, Zohaib Iqbal, Peter Turkington, Salman Razvi, Carel W. le Roux, Handrean Soran, and Akheel A. Syed. 2020. “ Obesity: A Critical Risk Factor in the COVID ‐19 Pandemic .” Clinical Obesity 10 (6). https://doi.org/10.1111/cob.12403.

Lee J.I., Burckart G.J. Nuclear factor kappa B: important transcription factor and therapeutic target. J. Clin. Pharmacol. 1998;38(11):981–993.

Liu, Jing, Sumeng Li, Jia Liu, Boyun Liang, Xiaobei Wang, Hua Wang, Wei Li, et al. 2020. “Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients.” EBioMedicine 55 (May). https://doi.org/10.1016/j.ebiom.2020.102763.

Liu, Yen Chin, Rei Lin Kuo, and Shin Ru Shih. 2020. “COVID-19: The First Documented Coronavirus Pandemic in History.” Biomedical Journal. Elsevier B.V. https://doi.org/10.1016/j.bj.2020.04.007.

Raghubeer, Shanel, and Tandi E. Matsha. 2021. “Methylenetetrahydrofolate (Mthfr), the One-Carbon Cycle, and Cardiovascular Risks.” Nutrients 13 (12). https://doi.org/10.3390/nu13124562.

Román, Gustavo C., Oscar Mancera-Páez, and Camilo Bernal. 2019. “Epigenetic Factors in Late-Onset Alzheimer’s Disease: MTHFR and CTH Gene Polymorphisms, Metabolic Transsulfuration and Methylation Pathways, and B Vitamins.” International Journal of Molecular Sciences 20 (2). https://doi.org/10.3390/ijms20020319.

Singhal, Tanu. 2020. “A Review of Coronavirus Disease-2019 (COVID-19).” Indian Journal of Pediatrics. Springer. https://doi.org/10.1007/s12098-020-03263-6.

Smith, A. D., and H. Refsum. 2021. “Homocysteine – from Disease Biomarker to Disease Prevention.” Journal of Internal Medicine. John Wiley and Sons Inc. https://doi.org/10.1111/joim.13279.

Wang, Jinxiang, Dingyun You, Huaping Wang, Yanhong Yang, Dan Zhang, Junyan Lv, Sufeng Luo, Rui Liao, and Lanqing Ma. 2021. “Association between Homocysteine and Obesity: A Meta-Analysis.” Journal of Evidence-Based Medicine 14 (3): 208–17. https://doi.org/10.1111/jebm.12412.

Zhang L, Liu Y (2020). Potential interventions for novel coronavirus in China: A systematic review. J of Med Vir, 92:479-490.

Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. (2004). Vitamin C pharmacokinetics: implications for oral and intravenous use. Annals of Int Med, 140:533-537